<--- Back to Details
First PageDocument Content
Medicine / Association of Commonwealth Universities / Consortium for North American Higher Education Collaboration / University of Manitoba / Canadian Institutes of Health Research / Public Health Agency of Canada / Winnipeg / Health Sciences Centre / Health promotion / Health / Health Canada / Provinces and territories of Canada
Date: 2014-07-07 16:53:32
Medicine
Association of Commonwealth Universities
Consortium for North American Higher Education Collaboration
University of Manitoba
Canadian Institutes of Health Research
Public Health Agency of Canada
Winnipeg
Health Sciences Centre
Health promotion
Health
Health Canada
Provinces and territories of Canada

COMMUNITY HEALTH SCIENCES

Add to Reading List

Source URL: umanitoba.ca

Download Document from Source Website

File Size: 242,79 KB

Share Document on Facebook

Similar Documents

Psychiatry / Psychiatric diagnosis / Health / Medical diagnosis / Bipolar spectrum / Depression / Major depressive disorder / RTT / Silencer / Mental health / Mental disorder / Immigration

Country of Origin as a Modifier of the effect of Generation and Length of Residence on the Mental Health Outcomes of Immigrants to Canada by Shirin Montazer

DocID: 1xUDn - View Document

2013 Annual Report HARNESSING A NEW ERA OF PARTNERSHIPS AND NETWORKS IN HEALTH INNOVATION THANK YOU TO OUR LEAD SPONSOR CANADA’S RESEARCH-BASED PHARMACEUTICAL COMPANIES

DocID: 1vr6Q - View Document

Developing novel NMDA receptor positive modulators as neuroprotectants Yu Tian Wang Djavad Mowafaghian Centre for Brain Health and Department of Medicine/Neurology, University of British Columbia, Vancouver, Canada The

DocID: 1vnMG - View Document

Occupational Health & Safety for Federally Regulated Workplaces The federal health and safety legislation is commonly referred to as Canada Labour Code Part II and regulations under the Code. The Canada Labour Code also

DocID: 1vn7y - View Document

PRESS RELEASE AbbVie Receives Health Canada Approval of HOLKIRATM PAK for the Treatment of Chronic Genotype 1 Hepatitis C  New all-oral, short-course (12 weeks), interferon-free treatment available in Canada for geno

DocID: 1vlwz - View Document